Amongst women who experience recurrent pregnancy loss, around 20% test positive for a specific antibody that targets the mother’s own body. A Kobe University-led research team now found a treatment that drastically increases these women’s chances of carrying to full-term without complications.
Tissue regeneration biotech raises $26M Series A to push toward clinical trials
A Maryland biotech led by an Army veteran and former West Point professor has raised an additional $26 million to move its targeted therapeutics platform
June 15, 2023